New weapons in the fight against colon cancer

Written by: Dr. Josep Tabernero Caturla
Published: | Updated: 17/11/2018
Edited by: Top Doctors®
. . . . . . . . . . . . . . . .

*Translated with Google translator. We apologize for any imperfection

By Dr. Josep Tabernero Caturla
Medical Oncology

Dr. Tabernero is the medical director of the Cancer Institute Baselga (IOB). In addition, he is Director of the Gastrointestinal Unit this center, Head of Oncology, University Hospital Vall d'Hebron in Barcelona and Head of the Gastrointestinal Tumor Medical Oncology Service of the same hospital. Besides director relevant international trials of new drugs in the treatment of digestive tumors, participates in numerous research projects of the European Union relating to advance cancer and is the Spanish representative of the Pan-European platform Trials in Alimentary Tract Cancer (PETACC ) treatment of digestive tumors in the European Organization for Research and Treatment of Cancer (EORTC). He is cofounder of the Spanish Group Treatment digestive tumors, and participates as an expert consultant in the preparation and development of Oncoguides of ESMO, SEOM and the Department of Health of the Generalitat de Catalunya.

*Translated with Google translator. We apologize for any imperfection

View Profile

Overall assessment of their patients